Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

Simon Peter Gampenrieder; Gabriel Rinnerthaler; Richard Greil

doi:10.1159/000368710

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

Simon Peter Gampenrieder (First author), Gabriel Rinnerthaler (Co-author), Richard Greil^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Review article › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	323-330
Journal	Breast care (Basel, Switzerland)
Volume	9
Issue number	5
DOIs	https://doi.org/10.1159/000368710
Publication status	Published - 2014

Keywords

PLACEBO-CONTROLLED TRIAL
SKELETAL-RELATED EVENTS
DISSEMINATED TUMOR-CELLS
CONTROLLED PHASE-III
ZOLEDRONIC ACID
PROSTATE-CANCER
DOUBLE-BLIND
ADJUVANT THERAPY
ORAL IBANDRONATE
SOLID TUMORS

Access to Document

10.1159/000368710

Cite this

@article{1bed2ea6f67f4951a9bf2bca5b3898b2,

title = "Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?",

keywords = "PLACEBO-CONTROLLED TRIAL, SKELETAL-RELATED EVENTS, DISSEMINATED TUMOR-CELLS, CONTROLLED PHASE-III, ZOLEDRONIC ACID, PROSTATE-CANCER, DOUBLE-BLIND, ADJUVANT THERAPY, ORAL IBANDRONATE, SOLID TUMORS",

author = "Gampenrieder, {Simon Peter} and Gabriel Rinnerthaler and Richard Greil",

year = "2014",

doi = "10.1159/000368710",

language = "English",

volume = "9",

pages = "323--330",

journal = "Breast care (Basel, Switzerland)",